Deciphering epigenetic regulation of enhancers in high‐risk prostate cancer

Article Properties
  • Language
    English
  • DOI (url)
  • Publication Date
    2024/02/01
  • Indian UGC (journal)
  • Refrences
    35
  • A. V. Tuzova UCD School of Biology and Environmental Science University College Dublin Dublin IrelandCancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research University College Dublin Dublin Ireland
  • B. Moran Ireland East Hospital Group, St Vincent's University Hospital Dublin Ireland ORCID (unauthenticated)
  • N. M. Russell Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research University College Dublin Dublin IrelandUCD School of Biomolecular and Biomedical Science, Conway Institute University College Dublin Dublin Ireland
  • S. Das School of Pharmacy & Biomolecular Sciences Royal College of Surgeons Ireland
  • F. Delahaye Michael F Price Centre Albert Einstein College of Medicine New York USA
  • R. Silva UCD School of Biology and Environmental Science University College Dublin Dublin IrelandCancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research University College Dublin Dublin Ireland
  • C. Barrett Department of Histopathology Mater Misericordia Hospital Dublin Ireland
  • R. W. G. Watson UCD School of Medicine University College Dublin Dublin Ireland ORCID (unauthenticated)
  • A. O'Neill UCD School of Medicine University College Dublin Dublin Ireland
  • W. M. Gallagher Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research University College Dublin Dublin IrelandUCD School of Biomolecular and Biomedical Science, Conway Institute University College Dublin Dublin Ireland
  • J. Greally Michael F Price Centre Albert Einstein College of Medicine New York USA
  • A. S. Perry UCD School of Biology and Environmental Science University College Dublin Dublin IrelandCancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research University College Dublin Dublin Ireland ORCID (unauthenticated)
Abstract
Cite
Tuzova, A. V., et al. “Deciphering Epigenetic Regulation of Enhancers in high‐risk Prostate Cancer”. Genes, Chromosomes and Cancer, vol. 63, no. 2, 2024, https://doi.org/10.1002/gcc.23218.
Tuzova, A. V., Moran, B., Russell, N. M., Das, S., Delahaye, F., Silva, R., Barrett, C., Watson, R. W. G., O’Neill, A., Gallagher, W. M., Greally, J., & Perry, A. S. (2024). Deciphering epigenetic regulation of enhancers in high‐risk prostate cancer. Genes, Chromosomes and Cancer, 63(2). https://doi.org/10.1002/gcc.23218
Tuzova, A. V., B. Moran, N. M. Russell, S. Das, F. Delahaye, R. Silva, C. Barrett, et al. “Deciphering Epigenetic Regulation of Enhancers in high‐risk Prostate Cancer”. Genes, Chromosomes and Cancer 63, no. 2 (2024). https://doi.org/10.1002/gcc.23218.
Tuzova AV, Moran B, Russell NM, Das S, Delahaye F, Silva R, et al. Deciphering epigenetic regulation of enhancers in high‐risk prostate cancer. Genes, Chromosomes and Cancer. 2024;63(2).
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
Science
Biology (General)
Genetics
Refrences
Title Journal Journal Categories Citations Publication Date
DNA methylation dynamics in cellular commitment and differentiation 2016
Cancer Genomics From Bench to Personalized Medicine 2014
DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes Genome Biology 226 2013
Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications Cold Spring Harbor Perspectives in Medicine
  • Medicine: Medicine (General)
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
21 2018
The long tail of oncogenic drivers in prostate cancer Nature Genetics
  • Science: Biology (General): Genetics
  • Science: Biology (General): Genetics
499 2018